3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
2
Sponsor Class
INDUSTRY
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Dermatologic
2
Conditions
Melanoma
688
Lymphoma, T-Cell, Cutaneous
116
Keratosis, Actinic
109
Skin Neoplasms
99
Carcinoma, Non-Small-Cell Lung
81
Mycosis Fungoides
79
Neoplasm Metastasis
78
Neoplasms
75
Sezary Syndrome
74
Lymphoma, Non-Hodgkin
72
Leukemia, Lymphocytic, Chronic, B-Cell
65
Lymphoma, Follicular
64
Lymphoma, Large B-Cell, Diffuse
63
Lymphoma, B-Cell, Marginal Zone
60
Precursor Cell Lymphoblastic Leukemia-Lymphoma
59
Lymphoma, Mantle-Cell
59
Uveal Melanoma
58
Carcinoma, Renal Cell
58
Carcinoma, Basal Cell
58
Lymphoma, Large-Cell, Immunoblastic
56
Hodgkin Disease
56
Burkitt Lymphoma
55
Lymphoma
52
Lymphoma, Large-Cell, Anaplastic
50
Waldenstrom Macroglobulinemia
44
Multiple Myeloma
44
Lymphoma, Extranodal NK-T-Cell
44
Breast Neoplasms
44
Immunoblastic Lymphadenopathy
43
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
41
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Has results
×
Skin Abnormalities
×
Dermatologic
×
Clear all
NCT05619471
2024-07-25
VISTA
Enspectra Health
Phase NA
Completed
65 enrolled
11 charts
NCT05410964
2024-01-30
VISION
Enspectra Health
Completed
122 enrolled
9 charts